T. Harayama et al. / Tetrahedron 60 (2004) 10645–10649
10649
(h) Osborne, D.; Stevenson, P. J. Tetrahedron Lett. 2002, 43,
5469–5470. (i) Lee, E. S.; Park, J.-G.; Jahng, Y. Tetrahedron
Lett. 2003, 44, 1883–1886. (j) Mhaske, S. B.; Argade, N. P.
J. Org. Chem. 2004, 69, 4563–4566.
SC NMR Laboratory of Okayama University for performing
the NMR experiments.
9. (a) Comins, D. L.; Baevsky, M. F.; Hong, H. J. Am. Chem. Soc.
1992, 114, 10971–10972. (b) Lytle, R. E.; Portlock, D. E.;
Kane, M. J.; Bristol, J. A. J. Org. Chem. 1972, 37, 3967–3968.
10. (a) Cabri, W.; Candiani, I. Acc. Chem. Res. 1995, 28, 2–7.
(b) Beletskaya, I. P.; Cheorakov, A. V. Chem. Rev. 2000, 100,
3009–3066.
References and notes
1. (a) Tsuji, J. Palladium Reagents and Catalysts; Wiley: New
York, 1995; pp 125–252. (b) Li, J. J.; Gribble, G. W.
Palladium in Heterocyclic Chemistry; Pergamon: Oxford,
2000. (c) Hassan, J.; Sevignon, M.; Gozzi, C.; Schulz, E.;
Lemaire, M. Chem. Rev. 2002, 102, 1359–1469.
11. No coupling reaction occurred using CH3CN in place of DMF
as the solvent.
12. (a) Banert, K.; Hagedorn, M.; Liedtke, C.; Melzer, A.;
Schaeffler, C. Eur. J. Org. Chem. 2000, 257. (b) Wasserman,
H. H.; Marino, P. S.; Keehn, P. M. J. Org. Chem. 1971, 36,
1765.
´ ´
(d) Echavarren, A. M.; Gomez-Lor, B.; Gonzalez, J. J.; de
´
Frutos, O. Synlett, 585–597.
2. (a) Harayama, T.; Shibaike, K. Heterocycles 1998, 49,
191–195. (b) Harayama, T.; Akiyama, T.; Akamatsu, H.;
Kawano, K.; Abe, H.; Takeuchi, Y. Synthesis 2001, 444–450.
(c) Harayama, T.; Akamatsu, H.; Okamura, K.; Miyagoe, T.;
Akiyama, T.; Abe, H.; Takeuchi, Y. J. Chem. Soc., Perkin
Trans. 1 2001, 523–528. (d) Harayama, T.; Akiyama, T.;
Nakano, Y.; Nishioka, H.; Abe, H.; Takeuchi, Y. Chem.
Pharm. Bull. 2002, 50, 519–522. (e) Harayama, T.; Akiyama,
T.; Nakano, Y.; Shibaike, K.; Akamatsu, H.; Hori, A.; Abe, H.;
Takeuchi, Y. Synthesis 2002, 237–241. (f) Harayama, T.; Hori,
A.; Nakano, Y.; Akiyama, T.; Abe, H.; Takeuchi, Y.
Heterocycles 2002, 58, 159–164. (g) Harayama, T.; Sato, T.;
Nakano, Y.; Abe, H.; Takeuchi, Y. Heterocycles 2003, 59,
293–301. (h) Harayama, T.; Morikami, Y.; Shigeta, Y.; Abe,
H.; Takeuchi, Y. Synlett 2003, 847–848. (i) Harayama, T.;
Morikami, Y.; Hori, A.; Nishioka, H. T.; Abe, H.; Takeuchi, Y.
Heterocycles 2004, 62, 803–806. (j) Harayama, T.; Hori, A. T.;
Abe, H.; Takeuchi, Y. Tetrahedron 2004, 60, 1611–1616.
(k) Abe, H.; Takeda, S.; Fujita, T.; Nishioka, K.; Takeuchi, Y.;
Harayama, T. Tetrahedron Lett. 2004, 45, 2327–2329.
(l) Harayama, T.; Sato, T.; Hori, A.; Abe, H.; Takeuchi, Y.
Synthesis 2004, 1446–1456. (m) Nishioka, H.; Shoujiguchi,
Y.; Abe, H.; Takeuchi, Y.; Harayama, T. Heterocycles 2004,
64, in press.
13. Asahina, Y.; Kashiwaki, K. Yakugaku Zasshi 1915, 405,
1273–1293.
14. Chu, J. H. Science Record (China) 1951, 4, 279–284.
15. (a) Woo, H. G.; Lee, C. H.; Noh, M.-S.; Lee, J. J.; Jung, Y.-S.;
Baik, E. J.; Moon, C.-H.; Lee, S. H. Planta Med. 2001, 67,
505–509. (b) Moon, T. C.; Murakami, M.; Kudo, I.; Son,
K. H.; Kim, H. P.; Kang, S. S.; Chang, H. W. Inflamm. Res.
1999, 621–625.
16. Itokawa, H.; Inamatsu, M.; Takeya, K. Shouyakugaku Zasshi
1990, 44, 135–137.
17. Sheen, W.-S.; Tsai, I.-L.; Teng, C.-M.; Ko, F.-N.; Chen, I.-S.
Planta Med. 1996, 62, 175–176.
18. (a) Hu, C.-P.; Xiao, L.; Deng, H.-W.; Li, Y.-J. Planta Med.
2003, 69, 125–129. (b) Hu, C.-P.; Xiao, L.; Deng, H.-W.; Li,
Y.-J. Planta Med. 2002, 68, 705–709. (c) Wang, W. F.; Wu,
C. J.; Chen, C. F.; Lin, L. C.; Huan, Y. T.; Shan, J.; Pang, P.
J. Pharmcol. Exp. Ther. 1999, 289, 1237–1244.
19. Yamahara, J.; Yamada, T.; Kitani, T.; Naitoh, Y.; Fujimura, H.
Chem. Pharm. Bull. 1989, 37, 1820–1822.
20. (a) Mhaske, S. B.; Argade, N. P. Tetrahedron 2004, 60,
3417–3420. (b) Chavan, S. P.; Sivappa, R. Tetrahedron Lett.
2004, 45, 997–999. (c) Lee, E. S.; Park, J.-G.; Jahng, Y.
Tetrahedron Lett. 2003, 44, 1883–1886. (d) Mohanta, P. K.;
Kim, K. Tetrahedron Lett. 2002, 43, 3993–3996. (e) Lee,
S. H.; Kim, S. I.; Park, J. G.; Lee, E. S.; Jahng, Y. Heterocycles
2001, 55, 1555–1559. (f) Yang, L.-M.; Chen, C.-F.; Lee, K.-H.
3. See Ref. 2h as the preliminary communication on the synthesis
of 1 and 2.
4. Ma, Z.-Z.; Hano, Y.; Nomura, T.; Chen, Y.-J. Heterocycles
1997, 46, 541–546.
5. Cagir, A.; Jones, S. H.; Gao, R.; Eisenhauer, B. M.; Hecht,
S. M. J. Am. Chem. Soc. 2003, 125, 13628–13629.
¨ ¨
Bioorg. Med. Chem. Lett. 1995, 5, 465–468. (g) Kokosi, J.;
´
Szasz, G.; Hermecz, I. Tetrahedron Lett. 1992, 33, 2995–2998.
6. Ma, Z.; Hano, Y.; Nomura, T.; Chen, Y. Bioorg. Med. Chem.
Lett. 2004, 14, 1193–1196.
(h) Eguchi, S.; Takeuchi, H.; Matsushita, Y. Heterocycles
1992, 33, 153–156. (i) Bergman, J.; Bergman, S. J. Org. Chem.
1985, 50, 1246–1255. (j) Mori, M.; Kobayashi, H.; Kimura,
M.; Ban, Y. Heterocycles 1985, 23, 2803–2806. (k) Kaneko,
C.; Chiba, T.; Kasai, K.; Miwa, C. Heterocycles 1985, 23,
1385–1390. (l) Bergman, J. In The Alkaloids; Brossi, A., Ed.;
Academic: New York, 1985; pp 30–54; and references cited
therein. (m) Asahina, Y.; Manske, R. H. F.; Robinson, R.
J. Chem. Soc. 1927, 1708–1710.
7. Xiao, X.-H.; Qou, G.-L.; Wang, H.-L.; Lui, L.-S.; Zheng,
Y.-L.; Jia, Z.-J.; Dreng, Z.-B. Chin. J. Pharmacol. Toxicol.
1988, 232–234.
8. (a) Wang, H.; Ganesan, A. Tetrahedron Lett. 1998, 39,
9097–9098. (b) Kelly, T. R.; Chamberland, H.; Silva, R. A.
Tetrahedron Lett. 1999, 40, 2723–2724. (c) Ma, Z.-Z.; Hano,
Y.; Nomura, T.; Chen, Y.-J. Heterocycles 1999, 51,
1593–1596. (d) Molina, P.; Tarraga, A.; Gonzalez-Tejero, A.
Synthesis 2000, 1523–1525. (e) Toyota, M.; Komori, C.; Ihara,
M. Heterocycles 2002, 56, 101–103. (f) Dallavalle, S.; Merlini,
L. Tetrahedron Lett. 2002, 43, 1835–1837. (g) Yadav, J. S.;
Reddy, B. V. S. Tetrahedron Lett. 2002, 43, 1905–1907.
21. Onda, M.; Kawanishi, M.; Sasamoto, M. Yakugaku Zasshi
1956, 76, 409–412.
22. Kametani, T.; Loc, C. V.; Higa, T.; Koizumi, M.; Ihara, M.;
Fukumoto, K. J. Am. Chem. Soc. 1977, 99, 2306–2309.